Care of Asymptomatic SARS-CoV-2 positive Kidney Transplant Recipients.


Creative Commons License

Velioglu A. , Tuglular S.

Transplant international : official journal of the European Society for Organ Transplantation, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume:
  • Publication Date: 2020
  • Doi Number: 10.1111/tri.13691
  • Title of Journal : Transplant international : official journal of the European Society for Organ Transplantation

Abstract

Sharing of experience amongst transplant community through various platforms and rapid publications has proven invaluable during the COVID‐19 pandemic (1‐3). The general consensus seemed to be that most kidney transplant recipients would have a moderate or mild course, although some may progress to a more severe disease. It was recommended to stop or decrease the dose of anti‐proliferative agents and continue with calcineurin inhibitors (CNIs) and maintenance steroids (4)